Dieter Ayers

2.8k total citations · 1 hit paper
32 papers, 1.7k citations indexed

About

Dieter Ayers is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Dieter Ayers has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Dieter Ayers's work include CAR-T cell therapy research (8 papers), Sepsis Diagnosis and Treatment (4 papers) and Diabetes Treatment and Management (4 papers). Dieter Ayers is often cited by papers focused on CAR-T cell therapy research (8 papers), Sepsis Diagnosis and Treatment (4 papers) and Diabetes Treatment and Management (4 papers). Dieter Ayers collaborates with scholars based in United States, Canada and United Kingdom. Dieter Ayers's co-authors include Joel Singer, Jeffrey Presneill, Anthony Gordon, Michelle Storms, Keith R. Walley, Cheryl L. Holmes, D. James Cooper, John Granton, Paul C. Hébert and James A. Russell and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Dieter Ayers

30 papers receiving 1.7k citations

Hit Papers

Vasopressin versus Norepinephrine Infusion in Patients wi... 2008 2026 2014 2020 2008 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dieter Ayers United States 14 998 548 367 362 351 32 1.7k
Caterina Fanizza Italy 15 785 0.8× 491 0.9× 485 1.3× 245 0.7× 392 1.1× 32 1.8k
Eliézer Silva Brazil 20 939 0.9× 404 0.7× 608 1.7× 214 0.6× 363 1.0× 50 1.8k
Pierre Perez France 15 708 0.7× 310 0.6× 289 0.8× 193 0.5× 338 1.0× 32 1.5k
Filomena Regina Barbosa Gomes Galas Brazil 21 686 0.7× 697 1.3× 660 1.8× 136 0.4× 429 1.2× 85 2.4k
Michael T. Bigham United States 23 708 0.7× 242 0.4× 268 0.7× 204 0.6× 382 1.1× 85 1.6k
John Pappachan United Kingdom 16 894 0.9× 278 0.5× 223 0.6× 76 0.2× 422 1.2× 57 1.7k
Gagan Kumar United States 21 739 0.7× 416 0.8× 307 0.8× 140 0.4× 202 0.6× 55 2.0k
Brian Warren South Africa 18 992 1.0× 530 1.0× 809 2.2× 85 0.2× 341 1.0× 28 2.4k
R. Philip Dellinger United States 5 1.1k 1.1× 356 0.6× 500 1.4× 170 0.5× 294 0.8× 11 1.5k
José António Lopes Portugal 25 423 0.4× 498 0.9× 288 0.8× 1.2k 3.2× 273 0.8× 95 2.0k

Countries citing papers authored by Dieter Ayers

Since Specialization
Citations

This map shows the geographic impact of Dieter Ayers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dieter Ayers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dieter Ayers more than expected).

Fields of papers citing papers by Dieter Ayers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dieter Ayers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dieter Ayers. The network helps show where Dieter Ayers may publish in the future.

Co-authorship network of co-authors of Dieter Ayers

This figure shows the co-authorship network connecting the top 25 collaborators of Dieter Ayers. A scholar is included among the top collaborators of Dieter Ayers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dieter Ayers. Dieter Ayers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolf, Jürgen, Sarah Goring, Adam Lee, et al.. (2025). Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC. Cancers. 17(5). 748–748.
4.
Shah, Nina, Dieter Ayers, Shannon Cope, et al.. (2022). Indirect treatment comparison of idecabtagene vicleucel versus conventional care in triple-class exposed multiple myeloma. Journal of Comparative Effectiveness Research. 11(10). 737–749. 10 indexed citations
6.
Paul, E., Andreas Kuznik, Chieh-I Chen, et al.. (2021). Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness Analysis. Value in Health. 24(3). 377–387. 17 indexed citations
7.
Ortíz, Alberto, Steve Kanters, Alaa Hamed, et al.. (2020). Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis. Clinical Kidney Journal. 14(4). 1136–1146. 17 indexed citations
8.
Cope, Shannon, Rachel Goldgrub, Dieter Ayers, et al.. (2019). Indirect comparison of nivolumab ± ipilimumab (CheckMate 032) versus other treatments for recurrent small-cell lung cancer. Journal of Comparative Effectiveness Research. 8(10). 733–751. 6 indexed citations
9.
Cope, Shannon, Dieter Ayers, Jie Zhang, Katharine Batt, & Jeroen P. Jansen. (2019). Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia. BMC Medical Research Methodology. 19(1). 182–182. 26 indexed citations
11.
Kanters, Steve, M. Eugenia Socías, Nicholas I. Paton, et al.. (2017). Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis. The Lancet HIV. 4(10). e433–e441. 52 indexed citations
12.
Mills, Edward J., Dieter Ayers, Roger Chou, & Kristian Thorlund. (2015). Are current standards of reporting quality for clinical trials sufficient in addressing important sources of bias?. Contemporary Clinical Trials. 45(Pt A). 2–7. 11 indexed citations
13.
Amed, Shazhan, Kim Reimer, Hans Krueger, et al.. (2014). Care delivery in youth with type 2 diabetes - are we meeting clinical practice guidelines?. Pediatric Diabetes. 15(7). 477–483. 7 indexed citations
14.
Mehta, Sangeeta, John Granton, Anthony Gordon, et al.. (2013). Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine. Critical Care. 17(3). R117–R117. 32 indexed citations
15.
Amed, Shazhan, Kim Reimer, Hans Krueger, et al.. (2013). Adherence to Clinical Practice Guidelines in the Management of Children, Youth, and Young Adults with Type 1 Diabetes—A Prospective Population Cohort Study. The Journal of Pediatrics. 163(2). 543–548.e1. 42 indexed citations
16.
Mehta, Sangeeta, Stephen E. Lapinsky, Gary E. Newton, et al.. (2011). Agreement in electrocardiogram interpretation in patients with septic shock*. Critical Care Medicine. 39(9). 2080–2086. 12 indexed citations
17.
Angel, Jonathan B., Jean‐Pierre Routy, Cécile Tremblay, et al.. (2011). A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune. AIDS. 25(6). 731–739. 35 indexed citations
18.
Ayers, Dieter, Joel Singer, P. Richard Harrigan, et al.. (2010). Connection Domain Mutations in Treatment-Experienced Patients in the OPTIMA Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(2). 160–166. 16 indexed citations
19.
Gordon, Anthony, James A. Russell, Keith R. Walley, et al.. (2009). The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Medicine. 36(1). 83–91. 158 indexed citations
20.
Russell, James A., Keith R. Walley, Joel Singer, et al.. (2008). Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock. New England Journal of Medicine. 358(9). 877–887. 1073 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026